Litcius/Paper detail

Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial

Mahamadou S. Sissoko, Sara A. Healy, Abdoulaye Katilé, Irfan Zaidi, Zonghui Hu, Bourama Kamaté, Yacouba Samake, Kourane Sissoko, Agnes Mwakingwe-Omari, Jacquelyn Lane, Alemush Imeru, Rathy Mohan, Ismaila Théra, Cheick Oumar Guindo, Amagana Dolo, Karamoko Niaré, Fanta Koïta, Amadou Niangaly, Kelly M. Rausch, Amatigué Zéguimé, Merepen A. Guindo, Aissatou Bah, Yonas Abebe, Eric R. James, Anita Manoj, Tooba Murshedkar, Natasha KC, B. Kim Lee Sim, Peter F. Billingsley, Thomas L. Richie, Stephen L. Hoffman, Ogobara K. Doumbo, Patrick E. Duffy

2021The Lancet Infectious Diseases79 citationsDOIOpen Access PDF

Topics & Concepts

MalariaMalaria vaccineMedicinePlasmodium falciparumTolerabilityRegimenImmunogenicityClinical trialVaccine efficacyVirologyAdverse effectInternal medicineImmunologyVaccinationAntibodyMalaria Research and ControlParasites and Host InteractionsVector-borne infectious diseases
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial | Litcius